The Cooper Companies, Inc. (COO) Return on Assets (ROA): 1.89%
Is The Cooper Companies, Inc.’s return on assets (ROA) high or low?
The Cooper Companies, Inc.'s return on assets (ROA) of 1.89% is 75% below its 5-year average of 7.71%, near the low end of its 5-year range (1.89%–30.65%).
As of Sunday, June 14, 2026. 39.13% below its 12-month average of 3.10%.
COO Return on Assets (ROA) Chart
COO Average Return on Assets (ROA) Chart
COO Current vs Average Return on Assets (ROA) Chart
COO Return on Assets (ROA) Metrics
RETURN ON ASSETS (ROA)
1.89%
RETURN ON ASSETS (ROA) AVG TTM
3.10%
RETURN ON ASSETS (ROA) AVG 3Y
3.02%
RETURN ON ASSETS (ROA) AVG 5Y
7.71%
RETURN ON ASSETS (ROA) AVG 10Y
6.76%
RETURN ON ASSETS (ROA) AVG 15Y
6.84%
RETURN ON ASSETS (ROA) AVG 20Y
5.83%
CURRENT VS TTM AVG
-39.13%
CURRENT VS 3Y AVG
-37.47%
CURRENT VS 5Y AVG
-75.50%
CURRENT VS 10Y AVG
-72.04%
CURRENT VS 15Y AVG
-72.37%
CURRENT VS 20Y AVG
-67.60%
COO Competitors' Return on Assets (ROA)
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| The Cooper Companies, Inc. (COO) | $13.24B | 1.89% | 3.10% | 3.02% | 7.71% |
| Solventum Corporation (SOLV) | $13.66B | 10.16% | 7.10% | 8.43% | 7.35% |
| Align Technology, Inc. (ALGN) | $12.52B | 6.81% | 6.68% | 6.69% | 12.75% |
| Baxter International Inc. (BAX) | $10.77B | -5.53% | -3.64% | -1.62% | 0.47% |
| Walgreens Boots Alliance, Inc. (WBA) | $10.37B | -9.07% | -6.92% | -1.48% | 0.07% |
| Hologic, Inc. (HOLX) | $16.97B | 5.92% | 7.45% | 8.56% | 11.79% |
| Charles River Laboratories International, Inc. (CRL) | $9.03B | -2.39% | -0.94% | 2.58% | 3.75% |
| Tempus AI, Inc. (TEM) | $8.35B | -14.19% | -43.49% | -42.71% | -41.26% |
| Bio-Rad Laboratories, Inc. (BIO) | $7.73B | 1.72% | -6.26% | -11.14% | 1.46% |
| Moderna, Inc. (MRNA) | $19.80B | -27.80% | -24.02% | -10.32% | -0.33% |
Asset Efficiency
ROA
1.9%
ROE
2.9%
The Cooper Companies, Inc. Return on Assets (ROA) Formula & Definition
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
The Cooper Companies, Inc. Return on Assets (ROA) FAQ
- What is the return on assets (ROA) for The Cooper Companies, Inc. (COO)?
- The return on assets (ROA) for COO stock is 1.89%.
- Is The Cooper Companies, Inc.'s return on assets (ROA) high or low?
- The Cooper Companies, Inc.'s return on assets (ROA) of 1.89% is 75% below its 5-year average of 7.71%, near the low end of its 5-year range (1.89%–30.65%).
- What is the TTM average return on assets (ROA) for The Cooper Companies, Inc. (COO)?
- The TTM average return on assets (ROA) for COO stock is 3.10%.
- What is the 3Y average return on assets (ROA) for The Cooper Companies, Inc. (COO)?
- The 3Y average return on assets (ROA) for COO stock is 3.02%.
- What is the 5Y average return on assets (ROA) for The Cooper Companies, Inc. (COO)?
- The 5Y average return on assets (ROA) for COO stock is 7.71%.
- What is the 10Y average return on assets (ROA) for The Cooper Companies, Inc. (COO)?
- The 10Y average return on assets (ROA) for COO stock is 6.76%.
- What is the 15Y average return on assets (ROA) for The Cooper Companies, Inc. (COO)?
- The 15Y average return on assets (ROA) for COO stock is 6.84%.
- What is the 20Y average return on assets (ROA) for The Cooper Companies, Inc. (COO)?
- The 20Y average return on assets (ROA) for COO stock is 5.83%.
The Cooper Companies, Inc. Return on Assets (ROA) History
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-10-31 | 3.02% |
| 2024-10-31 | 3.19% |
| 2023-10-31 | 2.52% |
| 2022-10-31 | 3.36% |
| 2021-10-31 | 30.65% |
| 2020-10-31 | 3.54% |
| 2019-10-31 | 7.44% |
| 2018-10-31 | 2.29% |
| 2017-10-31 | 7.67% |
| 2016-10-31 | 6.12% |
| 2015-10-31 | 4.56% |
| 2014-10-31 | 6.05% |
| 2013-10-31 | 9.44% |
| 2012-10-31 | 8.44% |
| 2011-10-31 | 6.68% |
| 2010-10-31 | 4.47% |
| 2009-10-31 | 3.94% |
| 2008-10-31 | 2.53% |
| 2007-10-31 | -0.44% |
| 2006-10-31 | 2.82% |
| 2005-10-31 | 4.21% |
| 2004-10-31 | 11.44% |
| 2003-10-31 | 9.75% |
| 2002-10-31 | 8.56% |
| 2001-10-31 | 9.36% |
| 2000-10-31 | 8.98% |
| 1999-10-31 | 8.78% |
| 1998-10-31 | 13.45% |
| 1997-10-31 | 17.91% |
| 1996-10-31 | 16.13% |
Related Metrics
About The Cooper Companies, Inc.
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Albert G. White